» Articles » PMID: 28965306

Current Treatment Options: Vestibular Migraine

Overview
Specialty Neurology
Date 2017 Oct 2
PMID 28965306
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Vestibular migraine (VM) is a disorder with a spectrum of clinical presentations and among the most common causes of chronic vestibular symptoms. Some present with attacks before or during typical migraine, but many others have fluctuating or daily symptoms. While the symptoms and pathogenesis of vestibular migraine may have elements of both central and peripheral disorders, hearing loss should be absent. VM typically worsens with activity and head movements in general, and encompasses symptoms of vertigo, disequilibrium, or imbalance. While it is possible to confuse other disorders such as Meniere's disease with migraine, it is worth making the diagnosis of vestibular migraine on clinical grounds after ruling out other possible causes. For acute attack treatment, migraine-specific medications such as triptans may be effective. In patients with frequent or disabling attacks, preventive treatment is essential. Vestibular rehabilitation may be helpful as well as medications used for migraine prevention such as including propranolol, venlafaxine, topiramate, and amitriptyline. For refractory patients, use of acetazolamide or lamotrigine may be reasonable.

Citing Articles

Case Report: Tadpole pupil and concurrent migraine in an adolescent patient is a novel correlation.

Scheid A, Gammelgaard Henneberg R, Hansen J Front Pediatr. 2024; 12:1446691.

PMID: 39439448 PMC: 11493630. DOI: 10.3389/fped.2024.1446691.


Adverse Events and Efficacy of Acetazolamide in Meniere's Disease in a Vertigo Outpatient Clinic: A Retrospective Study.

Kamogashira T, Asakura S, Funayama H, Ishimoto S Cureus. 2024; 16(9):e69616.

PMID: 39429303 PMC: 11486632. DOI: 10.7759/cureus.69616.


The role of selective serotonin reuptake inhibitors and tricyclic antidepressants in addressing reduction of Meniere's disease burden: A scoping review.

Missner A, Sheykhsoltan M, Hakimi A, Hoa M World J Otorhinolaryngol Head Neck Surg. 2024; 10(3):206-212.

PMID: 39233854 PMC: 11369805. DOI: 10.1002/wjo2.128.


Breaking the cycle: unraveling the diagnostic, pathophysiological and treatment challenges of refractory migraine.

Robblee J Front Neurol. 2023; 14:1263535.

PMID: 37830088 PMC: 10565861. DOI: 10.3389/fneur.2023.1263535.


Migraine management for the otolaryngologist.

Brooks K, Tawk K, Djalilian H, Hobson C Laryngoscope Investig Otolaryngol. 2023; 8(4):1080-1093.

PMID: 37621262 PMC: 10446291. DOI: 10.1002/lio2.1109.


References
1.
Dieterich M, Brandt T . Episodic vertigo related to migraine (90 cases): vestibular migraine?. J Neurol. 1999; 246(10):883-92. DOI: 10.1007/s004150050478. View

2.
Shin J, Kim Y, Kim H, Kim J . Altered brain metabolism in vestibular migraine: comparison of interictal and ictal findings. Cephalalgia. 2013; 34(1):58-67. DOI: 10.1177/0333102413498940. View

3.
Ruiz L, Ferrandi D . Topiramate in migraine progression. J Headache Pain. 2009; 10(6):419-22. PMC: 3476219. DOI: 10.1007/s10194-009-0164-9. View

4.
Geser R, Straumann D . Referral and final diagnoses of patients assessed in an academic vertigo center. Front Neurol. 2012; 3:169. PMC: 3508265. DOI: 10.3389/fneur.2012.00169. View

5.
Taghdiri F, Togha M, Jahromi S, Refaeian F . Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study. Springerplus. 2014; 3:231. PMC: 4021030. DOI: 10.1186/2193-1801-3-231. View